Health Technology · Pharmaceuticals: Major · NSE: ZENITHDRUG · data 2026-10-09
Zenith Drugs Ltd.
Health check: Average (4.9/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹40.6
Market cap
₹71 cr
P/E
17.7
P/B
1
ROE
5.5%
ROCE
9.3%
Debt / equity
0.75
Dividend yield
0.00%
1-year return
-36.1%
52-week high
₹65.5
52-week low
₹33.3
Operating margin
3.6%
Growth
| Revenue (last 12 months) | ₹171 cr |
| Net profit (last 12 months) | ₹4 cr |
| Sales growth, 3 years (yearly) | 14.3% |
| Profit growth, 3 years (yearly) | -8.5% |
Similar companies
Vaishali Pharma Ltd. (VAISHALI) · Vilin Bio Med Ltd. (VILINBIO) · Sunil Healthcare Ltd. (SUNLOC) · Onyx Biotec Ltd. (ONYX) · Vivimed Labs Limited (VIVIMEDLAB)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open ZENITHDRUG in NSE Scanner →